Erle T. Mast, Executive VP and CFO at Clovis Oncology, Inc. (CLVS), sold 3,000 shares at $92.09 ($271K) on 2015-10-01, disclosed to the SEC on 2015-10-02.
Scheduled sale ($271k) by Executive VP and CFO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $89.40 | 900 | $80K | 29.7% |
| 2 | $90.28 | 1,580 | $143K | 52.7% |
| 3 | $91.30 | 420 | $38K | 14.2% |
| 4 | $92.09 | 100 | $9K | 3.4% |
| Total | $90.22 avg | 3,000 | $271K | 100% |
| Filing → |
| SNNA | BUY | 2017-08-01 | $101K | — | Filing → |
| CLVS | SELL | 2015-11-03 | $317K | — | Filing → |
| CLVS | SELL | 2015-09-03 | $239K | — | Filing → |